BENDHEIM JACK (President and CEO) sold 9.7% of their position (4.81K shares) of PHIBRO ANIMAL HEALTH CORP on the open market
Open‑market sale worth $192.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 12/10/2025ACC: 0001104659-25-119982
DirectorOfficer10% Owner· President and CEO
Since Jul 2018
-4.81K
Net shares
Net seller
$192.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
4.81K disposed
Non-Derivative Transactions2
Class A Common Stock
Indirect
Shares
−3.52K
Price / share
$40.06
Trade value
$141.02K
% of position
7.1%
12/8/2025
49.76K→46.24K
Class A Common Stock
Indirect
Shares
−1.29K
Price / share
$40.19
Trade value
$51.76K
% of position
2.8%
12/9/2025
46.24K→44.95K
Total
Net shares
−4.81K
Net value
-$192.78K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Indirect | 12/8/2025 | S · Sale | −3.52K | $40.06 | $141.02K | 7.1% | 49.76K | 46.24K |
| Class A Common Stock Indirect | 12/9/2025 | S · Sale | −1.29K | $40.19 | $51.76K | 2.8% | 46.24K | 44.95K |
| Total | −4.81K | -$192.78K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Common Stock
DirectShares owned16.84K
Total
16.84K direct16.84K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 16.84K | Direct |
| Total | 16.84K | 16.84K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported